InstaDeep

What InstaDeep does

InstaDeep, founded in Tunisia in 2015 by Karim Beguir and Zohra Slim and now headquartered in London, delivers AI-powered decision-making systems for enterprise customers across life sciences, agriculture, electronics manufacturing, logistics, and energy. The company builds proprietary foundation models (Nucleotide Transformer for genomics, Bayesian Flow Networks for antibody and protein design, Oryx for multi-agent reinforcement learning, SegmentNT for genome annotation, InstaNovo for peptide sequencing), productised platforms (DeepChain for protein/biologics design, DeepPCB for printed-circuit-board automation, DeepPack for packaging optimisation, AIchor for ML orchestration at ~15,000 experiments per month), and operates the Kyber near-exascale GPU supercomputer in Paris. Its underlying technology stack combines GPU-accelerated computing, deep learning, and reinforcement learning, with select capabilities published in Nature Machine Intelligence, Nature Methods, and NeurIPS.

The company operates a hybrid go-to-market combining enterprise AI solutions for large industrial customers (BioNTech, Syngenta, Wilo, Google) with self-serve product subscriptions for DeepPCB Pro, DeepChain, DeepPack, and AIchor. Revenue is generated through negotiated enterprise contracts and platform subscriptions with annual billing; pricing tiers are not publicly disclosed. Distribution is multi-channel: direct enterprise sales, technology partner channels (NVIDIA Elite Partner, Google Cloud, Dell), and OEM-style embedding within BioNTech since the July 2023 acquisition for approximately £362 million, which made InstaDeep a wholly-owned subsidiary of BioNTech SE.

Post-acquisition, InstaDeep continues to operate under its own brand with offices in London, Paris, Tunis, Lagos, Nairobi, Cambridge MA, and San Francisco, and a global workforce of 251-500 employees. Strategic activity has accelerated rather than slowed under BioNTech ownership, evidenced by the 2024 Kyber supercomputer launch, the 2025 AI Day full-stack ecosystem showcase, a sustained model-release cadence in 2025-2026 (AbBFN2, SegmentNT, NTv3, InstaNovo v2, mlip, DEgym, MEMENTO, Oryx), and a 2026 strategic partnership with Wilo Group extending into smart water infrastructure.

Name

InstaDeep

Legal name

InstaDeep Ltd

Website

https://instadeep.com

Company type

Private

Founded year

2015

Operating status

Acquired

Headcount range

251–500 employees

Short description

InstaDeep, a BioNTech-owned AI research company founded in 2015 in Tunisia and headquartered in London, builds proprietary foundation models and AI products for life sciences, agriculture, electronics, logistics, and energy enterprises. It operates the Kyber supercomputer and the DeepChain, DeepPCB, and AIchor platforms.

Ownership category

akta.pro rank

Product category

Enterprise AI Software

NAICS

Computer Systems Design and Related Services (5415), Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

AI Integration & Orchestration Platforms (Connectors, Workflow, iPaaS for AI) (HDAEANAI)

Keywords

• Enterprise AI systems
• AI drug discovery
• Protein design AI
• PCB design automation
• ML orchestration platform

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Enterprise AI Solutions: Custom AI decision-making systems developed and deployed for enterprise customers across life sciences, logistics, electronics, and energy sectors. Revenue generated through project-based contracts and long-term engagements.
2. AI Software Products: Self-serve AI products including DeepChain (protein analysis), DeepPCB (PCB design), DeepPack, and AIchor (ML orchestration) offered as platform subscriptions or usage-based pricing.
3. Acquisition by BioNTech: Following acquisition by BioNTech in 2023, InstaDeep operates as a wholly-owned subsidiary generating revenue through integration into BioNTech's AI-driven drug discovery operations.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

InstaDeep delivers AI-powered decision-making systems for enterprise customers across biology, logistics, electronic design, and energy sectors. The company builds proprietary AI foundation models (Nucleotide Transformer, Bayesian Flow Networks), AI products (DeepChain for protein design, DeepPCB for circuit board design, DeepPack for logistics, AIchor for ML orchestration), and runs near-exascale supercomputing infrastructure (Kyber). Following its 2023 acquisition by BioNTech, InstaDeep operates as a wholly-owned subsidiary focused on AI-driven drug discovery and immunotherapy development.

Product overview

InstaDeep delivers AI-powered decision-making systems for the enterprise through a platform-plus-products architecture. The core offering combines proprietary AI models and tools across four domains: Biology (DeepChain for protein/biologics design, Nucleotide Transformer genomics models, AbBFN2 antibody design, InstaNovo peptide sequencing, SegmentNT genome annotation), Electronic Design (DeepPCB/DeepPCB Pro for PCB design), Logistics (DeepPack for packaging optimization), and Infrastructure (AIchor orchestration platform, Kyber supercomputer). The company also provides open-source tools including mlip for molecular simulations and DEgym for reinforcement learning environments. Products are built on GPU-accelerated computing, deep learning, and reinforcement learning technologies, with major partnerships with BioNTech (acquired in 2023), Google Cloud, NVIDIA, and Syngenta.

Differentiator

Problem solved

Functional benefit

Brands

• DeepChain: AI platform for biological research and protein design
• DeepPack
• DeepPCB
• AIchor
• Kyber
• DeepPCB Pro

Products and services

• DeepChain AI-powered protein and biologics design platform enabling researchers to design and optimize therapeutic antibodies, nanoparticles, and vaccine candidates through generative AI and molecular simulation tools. Used by biotech and pharma researchers for drug discovery and biological research.
• DeepPCB AI-powered Printed Circuit Board design tool using reinforcement learning that achieves fully automated PCB design, reducing design time by a factor of ten. Targeted at electronics design engineers and PCB designers.
• DeepPCB Pro Advanced version of DeepPCB developed in collaboration with Google Cloud, offering enhanced AI automation for PCB design optimization. Launched at Google's San Francisco offices in 2024.
• DeepPack AI solution for packaging optimization, leveraging machine learning to improve packaging design and logistics efficiency. Targeted at logistics and supply chain companies.
• AIchor ML orchestration platform that makes HPC infrastructure accessible through GitOps workflow, facilitating an average of 15,000 experiments per month across research teams. Used by ML engineers and researchers for AI workload management.
• Kyber Supercomputer Near-exascale supercomputer with ~0.5 exaFLOPs FP16 performance powered by NVIDIA H100 GPUs, ranking among the top 100 global AI clusters and top 20 H100 GPU clusters. Provides compute infrastructure for AI research and enterprise customers.
• mlip Library Open-source Machine Learning Interatomic Potentials library providing near-quantum accuracy for molecular simulations using MACE, NequIP, and ViSNet models with ASE and JAX MD wrappers. Targeted at computational chemistry researchers.
• Nucleotide Transformer (NT) Family of DNA foundation models for genomics including NTv3 capable of 1Mb single-nucleotide-resolution prediction, representation learning, and generative regulatory design across 150,000+ species. Used by genomic researchers and biologists.
• AbBFN2 Multimodal Bayesian Flow Network for antibody design achieving 90% success rate in humanization (under 20 minutes vs months in lab), optimizing biophysics alongside humanness. Targeted at antibody engineers and immunologists.
• InstaNovo Library-free de novo peptide sequencing algorithm trained on 63 million labelled spectra, delivering 10-15% accuracy increase and 50-fold faster inference for protein identification. Used by proteomics researchers.
• SegmentNT Extension of Nucleotide Transformer for genome annotation at single-nucleotide resolution, detecting 14 genomic element classes including exons, introns, splice sites, and regulatory elements across sequences up to 50kb. Targeted at genomic researchers.
• Oryx Scalable sequence model for multi-agent reinforcement learning enabling coordination among up to 50 agents in offline settings for autonomous driving, warehouse logistics, intelligent rail networks, and satellite alignment.
• DEgym

Quantifiable outcome

• 10x reduction in PCB design time through DeepPCB AI tool
• +5 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature10 records

Partnerships

Seven partnerships are on record, tiered core and flagship.

• Wilo GroupcoreStrategic or Co-development Partner · 1 March 2026Long-term strategic partnership to develop scalable AI platform for smart water infrastructure. Agreement signed at Wilo's headquarters in Germany, with development teams already collaborating on initial pilot project. Focus on integrating AI into water technology applications for critical infrastructure management.
• Dell TechnologiescoreTechnology or Integration · 1 October 2024SCC France partnered with Dell to integrate and optimize Kyber supercomputer infrastructure powered by Dell PowerEdge XE-series servers and NVIDIA H100 GPUs. Partnership achieved up to 40% faster AI model training times and 30% cost reduction.
• Google CloudcoreTechnology or Integration · 1 September 2024Collaboration on DeepPCB Pro - AI-powered PCB design tool launched at Google's San Francisco offices. Uses Google Cloud TPU for scalable reinforcement learning to improve DeepPCB.
• SyngentacoreStrategic or Co-development Partner · 1 June 2024Strategic collaboration to accelerate crops and seeds trait research using AI large language models. The partnership combines Syngenta's agricultural expertise with InstaDeep's AI capabilities to reduce research cycle time and bolster decision science for corn and soybean crops.
• BioNTechflagshipStrategic or Co-development Partner · 1 July 2023BioNTech acquired InstaDeep in July 2023 for approximately £562 million (Africa's largest AI exit). Prior to acquisition, companies had multi-year strategic collaboration including formation of AI Innovation Lab in 2020 and joint research on COVID-19 variant monitoring. Post-acquisition, InstaDeep operates as wholly-owned subsidiary strengthening BioNTech's AI-driven drug discovery capabilities.
• NVIDIAcoreTechnology or Integration · 1 March 2022Collaboration to use NVIDIA Cambridge-1 supercomputer for training AI language models on genomics data. InstaDeep was among select organizations granted access to Cambridge-1's supercomputing capabilities for drug discovery research.
• NVIDIAcoreTechnology or IntegrationNVIDIA Elite Partner; collaboration on Cambridge-1 supercomputer; access to NVIDIA H100 GPUs for Kyber supercomputer; technology partnership for AI infrastructure

Scale indicators8 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Isomorphic Labs: Alphabet-backed AI drug discovery company building foundation models for biology. Most direct competitor to InstaDeep's DeepChain and Nucleotide Transformer offerings, with substantially larger capital backing and exclusive pharma partnerships.
• Recursion Pharmaceuticals: AI-driven drug discovery platform combining high-throughput biology with machine learning. Comparable to InstaDeep's life sciences vertical in targeting accelerated therapeutic discovery through integrated AI and experimental platforms.
• Exscientia: AI-native pharma company focused on AI-designed small molecule drug discovery. Direct competitor to InstaDeep's antibody design and protein engineering capabilities, with established pharma partnerships and clinical-stage assets.
• Insitro: Machine learning-driven drug discovery company combining ML with high-throughput experimental biology. Operates in overlapping life sciences AI territory with similar enterprise pharma partnerships and foundation model ambitions.
• BenevolentAI: AI-driven drug discovery company applying knowledge graphs and ML to target identification. Comparable life sciences AI positioning with established pharma collaborations and disease-area focus.

Emerging players

• Cradle Bio: AI protein design company enabling scientists to engineer proteins with desired properties. Direct overlap with InstaDeep's AbBFN2 and ProtBFN protein modeling work, though earlier-stage and narrower in scope.
• EvolutionaryScale: AI research company building frontier biological foundation models. Emerging competitor in the same protein and biology model category as InstaDeep's Nucleotide Transformer and BFN family.

Broad incumbents

• DeepMind: Alphabet's AI research division with AlphaFold and other foundational biology models. Operates as a broad incumbent whose foundation model releases (e.g., AlphaFold 3) directly compete with InstaDeep's genomics and protein offerings.
• DataRobot: Enterprise AI/ML platform vendor offering automated ML and MLOps orchestration. Comparable to InstaDeep's AIchor platform product line in targeting enterprise ML workflow and orchestration needs.
• Cadence Design Systems: Major electronic design automation (EDA) vendor offering PCB and IC design tools. Competes with InstaDeep's DeepPCB/DeepPCB Pro product in the electronic design vertical, with substantially larger market presence and incumbency.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/instadeepai
• GitHubgithub.com/instadeepai
• Facebookfacebook.com/InstaDeepAI
• LinkedInlinkedin.com/company/instadeep

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds5 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InstaDeep